NCT00152061View on ClinicalTrials.gov

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

August 31, 2005

Conditions
HIV Infections
Interventions
DRUG

3TC and FTC

Trial Locations (1)

95128

Santa Clara Medical Center, PACE Clinic, San Jose

All Listed Sponsors
collaborator

Santa Clara Valley Health & Hospital System

OTHER

collaborator

University of California, Davis

OTHER

lead

Stanford University

OTHER

NCT00152061 - The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens | Biotech Hunter | Biotech Hunter